{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:04:49Z","timestamp":1781780689361,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.taap.2006.01.008","type":"journal-article","created":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T19:20:38Z","timestamp":1141240838000},"page":"326-334","source":"Crossref","is-referenced-by-count":25,"title":["Increased FasL expression correlates with apoptotic changes in granulocytes cultured with oxidized clozapine"],"prefix":"10.1016","volume":"214","author":[{"given":"Zaheed","family":"Husain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Almeciga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C.","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga P.","family":"Clavijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Januario E.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Belalcazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Zu\u00f1iga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond J.","family":"Yunis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2006.01.008_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","article-title":"Clozapine-induced agranulocytosis. Incidence and risk factors in the United States","volume":"329","author":"Alvir","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2006.01.008_bib2","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM199103143241107","article-title":"Clozapine. A novel antipsychotic agent","volume":"324","author":"Baldessarini","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2006.01.008_bib3","first-page":"41","article-title":"The HL60 cell line: a model system for studying human myeloid differentiation","volume":"9","author":"Birnie","year":"1988","journal-title":"Br. J. Cancer, Suppl."},{"key":"10.1016\/j.taap.2006.01.008_bib4","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1182\/blood.V57.6.1000.1000","article-title":"Terminal differentiation of human promyelocytic leukemia cells in primary culture in response to retinoic acid","volume":"57","author":"Breitman","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.taap.2006.01.008_bib5","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood.V80.8.2012.2012","article-title":"Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products","volume":"80","author":"Colotta","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.taap.2006.01.008_bib6","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1182\/blood.V86.10.3835.bloodjournal86103835","article-title":"The major histocompatibility complex region marked by HSP70-1 and HSP70-2 variants is associated with clozapine-induced agranulocytosis in two different ethnic groups","volume":"86","author":"Corzo","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.taap.2006.01.008_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev.immunol.15.1.203","article-title":"Fc receptor biology","volume":"15","author":"Daeron","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.taap.2006.01.008_bib8","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood.V90.3.1267","article-title":"Fc(RII (CD32) is linked to apoptotic pathways in murine granulocyte precursors and mature eosinophils","volume":"90","author":"De Andres","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.taap.2006.01.008_bib9","first-page":"882","article-title":"In vitro effects of clozapine on hematopoietic progenitor cells","volume":"83","author":"Deliliers","year":"1998","journal-title":"Haematologica"},{"key":"10.1016\/j.taap.2006.01.008_bib10","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.4049\/jimmunol.153.3.1254","article-title":"Neutrophil apoptosis is associated with a reduction in CD16 (Fc(RIII) expression","volume":"153","author":"Dransfield","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2006.01.008_bib11","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood.V92.12.4808","article-title":"Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species","volume":"92","author":"Fadeel","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.taap.2006.01.008_bib12","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0002-9440(10)64779-7","article-title":"Mechanisms of apoptosis","volume":"157","author":"Reed","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.taap.2006.01.008_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/cimm.1998.1339","article-title":"Mice deficient in fas ligand (gld) or fas (lpr) show few alterations in granulopiesis","volume":"188","author":"Fecho","year":"1998","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.taap.2006.01.008_bib14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.jcp.0000177668.42640.fe","article-title":"Clozapine induces oxidative stress and proapototic gene expression in neutrophils of schizophrenic patients","volume":"25","author":"Fehsel","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.taap.2006.01.008_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/bbrc.1994.1036","article-title":"Butyrate induced apoptosis in lymphoid cells preceded by transient over-expression of HSP70 mRNA","volume":"198","author":"Filippovich","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2006.01.008_bib16","first-page":"846","article-title":"Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis","volume":"40","author":"Fischer","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2006.01.008_bib17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/excr.1997.3725","article-title":"Modulation of heat\u2013shock protein 70 (HSP70) gene expression by sodium butyrate in U-937 promonocytic cells: relationships with differentiation and apoptosis","volume":"236","author":"Garcia-Bermejo","year":"1997","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.taap.2006.01.008_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0198-8859(96)00064-X","article-title":"Tumor necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretion","volume":"50","author":"Garcia-Merino","year":"1996","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.taap.2006.01.008_bib19","first-page":"991","article-title":"A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes","volume":"53","author":"Gardner","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2006.01.008_bib20","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1021\/tx050095o","article-title":"A comparison of the covalent binding of clozapine, procainamide, and vesnarinone to human neutrophils in vitro and rat tissues in vitro and in vivo","volume":"18","author":"Gardner","year":"2005","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2006.01.008_bib21","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/01.chi.0000171904.23947.54","article-title":"Hematological adverse effects in clozapine-treated children and adolescents","volume":"44","author":"Gerbino-Rosen","year":"2005","journal-title":"J. Am. Acad. Child Adolesc. Psych."},{"key":"10.1016\/j.taap.2006.01.008_bib22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2141.1994.tb04786.x","article-title":"N-desmethylclozapine: a clozapine metabolite that suppresses haemopoiesis","volume":"86","author":"Gerson","year":"1994","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.taap.2006.01.008_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0300-483X(98)00110-3","article-title":"Examination of possible toxic and immune mechanisms of clozapine-induced agranulocytosis","volume":"131","author":"Guest","year":"1998","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2006.01.008_bib24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1348-0421.1996.tb01095.x","article-title":"Involvement of two types of TNF receptor in TNF-alpha induced neutrophil apoptosis","volume":"40","author":"Gon","year":"1996","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.taap.2006.01.008_bib25","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/eji.1830260817","article-title":"Expression and function of the Fas receptor on human blood and tissue eosinophils","volume":"26","author":"Hebestreit","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.taap.2006.01.008_bib26","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1182\/blood.V85.2.532.532","article-title":"Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V., binding sites during apoptosis in vitro","volume":"85","author":"Homburg","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.taap.2006.01.008_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10401230309085668","article-title":"Clozapine. A clinical review of adverse effects and management","volume":"15","author":"Iqbal","year":"2003","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.taap.2006.01.008_bib28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00131746-200509000-00003","article-title":"Examining concentration-dependent toxicity of clozapine: role of therapeutic drug monitoring","volume":"11","author":"Khan","year":"2005","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.taap.2006.01.008_bib29","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.4049\/jimmunol.155.7.3289","article-title":"Regulation of apoptosis in neutrophils-Fas track to death?","volume":"155","author":"Liles","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2006.01.008_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1084\/jem.184.2.429","article-title":"Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils","volume":"184","author":"Liles","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.taap.2006.01.008_bib31","first-page":"1463","article-title":"The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man","volume":"275","author":"Maggs","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2006.01.008_bib32","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2249.1990.tb08110.x","article-title":"HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis","volume":"79","author":"Martin","year":"1990","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.taap.2006.01.008_bib33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1600-0447.1989.tb06432.x","article-title":"Melperone and clozapine: neuroendocrine effects of atypical neuroleptic drugs","volume":"352","author":"Meltzer","year":"1989","journal-title":"Acta Psychiatr. Scand., Suppl."},{"key":"10.1016\/j.taap.2006.01.008_bib34","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/jlb.65.6.875","article-title":"Regulation of neutrophil FcgammaRIIIb (CD16) surface expression following delayed apoptosis in response to GM-CSF and sodium butyrate","volume":"65","author":"Moulding","year":"1999","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.taap.2006.01.008_bib35","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1182\/blood.V90.7.2772","article-title":"Regulation of neutrophil apoptosis by tumor necrosis factor-alpha: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro","volume":"90","author":"Murray","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.taap.2006.01.008_bib36","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.7533326","article-title":"The Fas death factor","volume":"267","author":"Nagata","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.taap.2006.01.008_bib37","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/jlb.67.3.374","article-title":"Changes in susceptibility to Fas-mediated apoptosis during differentiation of HL-60 cells","volume":"67","author":"Ohashi","year":"2000","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.taap.2006.01.008_bib38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00004714-199610000-00011","article-title":"Effects of clozapine on plasma cytokine and soluble cytokine receptor levels","volume":"16","author":"Pollmacher","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.taap.2006.01.008_bib39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0022-1759(94)90093-0","article-title":"The separation of granulocytes from different rat strains","volume":"167","author":"Szucs","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.taap.2006.01.008_bib40","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1182\/blood.V89.11.4167","article-title":"Tumor necrosis factor constellation polymorphism and clozapine-induced agranulocytosis in two different ethnic groups","volume":"89","author":"Turbay","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.taap.2006.01.008_bib41","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4049\/jimmunol.162.2.735","article-title":"Quantitative analysis of the effect of CD16 ligation on human NK cell poliferation","volume":"162","author":"Warren","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2006.01.008_bib42","first-page":"1375","article-title":"Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis","volume":"283","author":"Williams","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2006.01.008_bib43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/mol.58.1.207","article-title":"Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine","volume":"58","author":"Williams","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2006.01.008_bib44","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1182\/blood.V86.3.1177.1177","article-title":"HLA associations in clozapine-induced agranulocytosis","volume":"86","author":"Yunis","year":"1995","journal-title":"Blood"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X06000317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X06000317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T16:49:14Z","timestamp":1683391754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X06000317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0041008X06000317"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2006.01.008","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}